Tag:
Vermont
Latest Headlines
Latest Headlines
VT officials spotlight foreign financing role for stem cell facility
Almost two years after first announcing plans to build a new stem cell research and manufacturing center close to the Canadian border in Vermont, a joint venture set up by South Korea's AnC Bio and a
High court rules against Vermont in data-mining case
The Supreme Court ruled 6-3 Thursday that states may not prohibit the use of information about physician healthcare practices in the marketing of medicines. The decision strikes down a Vermont law
Supreme Court skeptical of VT data law
Vermont didn't make a very strong showing at the U.S. Supreme Court yesterday . Attempting to defend its law designed to keep data-mining companies from obtaining doctors' prescribing data for resale
Supreme Court to hear data-mining arguments
Do states have the right to make doctors' prescription data private? Or do data-mining companies have the right to gather that data and sell it? These are the questions before the U.S. Supreme Court
High court to weigh data-mining laws
The U.S. Supreme Court has decided to consider a case that could change the face of drug marketing. At issue is whether market research firms can collect prescription information and resell it to
Court overturns Vermont law on commerical use of doctor info
The U.S. Court of Appeals for the Second Circuit has determined that a Vermont law restricting the commercial use of information relating to physician prescribing patterns is unconstitutional. The
Want a free pharma latte? Show your ID
You've heard that there's no free lunch, but no free coffee? One of the trends noticed at last weekend's American Society of Clinical Oncology meeting was careful policing of just who took free
California rep backs ban on scrip data-mining
Another state is trying to put up a wall between drugmakers and patient prescription data. California state Assemblyman Bill Monning has introduced a bill that would prohibit the sale of doctors'
Vermont's mandated doc-payment disclosures show drop to $2.6M
Drugmakers appear to be backing away a bit from doc payments in Vermont, and experts are saying that it's because of disclosure requirements passed by the state legislature back in 2002. Is this a
Vermont mulls free-sample disclosure rule
Vermont, which has already reined in drugmakers' marketing , could become the first state to require pharma to report how much they're spending on free drug samples. Report
